Obstructive sleep apnea-hypopnea syndrome and allergic rhinitis
Conditions
Interventions
Experimental group,:None
Control Group:None
Sponsors
Baoding NO.1 central hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. The diagnosis of OSAHS complies with the standards of the "Diagnosis and Treatment Guidelines for OSAHS in Chinese Adults" and the "Diagnosis and Treatment Guidelines for Obstructive Sleep Apnea in Chinese Children (2020)". 2. The AR diagnosis complies with the standards of the "Guidelines for the Diagnosis and Treatment of Allergic Rhinitis" . 3. Age and basic condition: Aged between 5 and 70 years old, without having undergone nasopharyngeal surgery or systemic treatment for OSAHS/AR (such as CPAP, immunotherapy); 4. Voluntarily sign the informed consent form and commit to completing the 12-month follow-up and testing.
Exclusion criteria
Exclusion criteria: 1. Age mismatch; 2. Other nasal diseases, such as chronic sinusitis with nasal polyps (EPOS 2020 standard), nasal tumors, history of nasal trauma, and other diseases that may interfere with the assessment; 3. Systemic disease interference, such as severe cardiopulmonary diseases (NYHA cardiac function grade III-IV, COPD GOLD grade 3-4), immunodeficiency diseases (such as HIV/AIDS), and uncontrolled diabetes (HbA1c>=9%); 4. Drug or treatment interference, such as the use of immunosuppressants or biological agents (such as omalizumab) within the last 3 months; 5. Pregnant or lactating women; 6. Insufficient compliance, such as inability to cooperate with follow-up visits (such as living in a different place, mental illness) or refusal to undergo certain tests (such as repeated PSG or blood tests).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduce or increase; | — |
Secondary
| Measure | Time frame |
|---|---|
| Score.;Sleep apnea monitoring; | — |
Countries
China
Contacts
Public ContactZhaoWei
Baoding NO.1 central hospital
Outcome results
None listed